Navigation Links
USC researcher reveals how to better master stem cells' fate
Date:10/24/2013

USC scientist Qi-Long Ying and a team of researchers have long been searching for biotech's version of the fountain of youth ways to encourage embryonic stem cells (ESCs) and epiblast stem cells (EpiSCs) to endlessly self-renew, or divide to produce more stem cells.

In a pair of studies published in Nature Communications in September and in The EMBO Journal in August, Ying and his team revealed some of the ways that ESCs and EpiSCs retain their pluripotency, or ability to differentiate into virtually any kind of cell.

The study in Nature Communications identified a novel way of culturing human ESCs by focusing on the Wnt/beta-catenin signaling pathway a group of molecules that work together to control various cell functions, including some related to embryonic development.

Slide1 rev

(Illustration by Qing Liu-Michael)

According to the researchers, this pathway can prompt mouse EpiSCs and human ESCs to either self-renew or differentiate. When the protein beta-catenin remains within the cell cytoplasm but outside of the nucleus, the stem cell continues to self-renew. When beta-catenin moves into a stem cell's nucleus, differentiation begins.

Slide2 rev

(Illustration by Qing Liu-Michael)

The paper published in The EMBO Journal addresses mouse ESCs, which are derived from the embryo at an earlier stage and are more pluripotent than mouse EpiSCs.

The study revealed the important role of Tfcp2l1 a transcription factor, or protein that controls which genes are turned on and off in a cell.

In mice, Tfcp2l1 helps communicate to ESCs that they should self-renew. The transcription factor also shows promise for "rewinding" slightly more differentiated EpiSCs into the more nave ESC state.

By learning more about the ESC and EpiSC playbooks, Ying and his colleagues can better control stem cell self-renewal, offering hope for patients with currently untreatable diseases and creating potential for a wide variety of other applications.

"These new findings have allowed us to develop conditions for the efficient propagation of human ESCs, and might also enable us to establish pluripotent stem cells from different species," said Ying, associate professor of stem cell biology and regenerative medicine at the Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research at USC. "This has far-reaching implications for a variety of applied areas of investigation, ranging from manipulating the genomes of agricultural animals to developing stem cell-based therapies for ailments such as Parkinson's disease or spinal cord injuries."


'/>"/>

Contact: Cristy Lytal
lytal@med.usc.edu
University of Southern California - Health Sciences
Source:Eurekalert  

Related biology news :

1. Researchers identify gene variant that raises risk for colorectal cancer from eating processed meat
2. USC researcher learns how to break a sweat
3. Researchers show how plants tell the time
4. Berkeley Lab researchers get a detailed look at a DNA repair protein in action
5. Researchers capture images of open channel that moves proteins across cell membranes
6. UAlberta medical researchers discover potential new treatment for colitis
7. Older siblings cells can be passed from female dogs to their puppies in the womb, MU researchers find
8. Nitrogen fertilizer remains in soils and leaks towards groundwater for decades, researchers find
9. Researchers discover innate virus-killing power in mammals
10. CNIO researchers delve into the behavior of cohesins
11. AgriLife researcher Xiuren Zhang receives National Science Foundation CAREER grant
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
USC researcher reveals how to better master stem cells' fate
(Date:2/2/2017)... 2, 2017   TapImmune, Inc. (NASDAQ: ... specializing in the development of innovative peptide and ... cancer and metastatic disease, announced today it has ... of a second clinical lot of TPIV 200, ... alpha. The manufactured vaccine product will be used ...
(Date:1/31/2017)... 31, 2017  Spero Therapeutics, LLC, a biopharmaceutical ... treatment of bacterial infections, today announced it has ... from Pro Bono Bio Ltd (PBB) to bolster ... resistant forms of Gram-negative bacteria.   The assets acquired ... a PBB group company. "The acquisition ...
(Date:1/25/2017)... YORK , Jan. 25, 2017 The ... Access Management (IAM) lifecycle is comprised of a ... for the purpose of maintaining digital identities and ... resources and applications. There are significant number of ... from time to time by optimizing processes and ...
Breaking Biology News(10 mins):
(Date:2/23/2017)... ROCHESTER, Minn. , Feb. 23, 2017 /PRNewswire/ ... a new product line of oncolytic vaccinia viruses ... Genelux Corporation as part of Genelux,s proprietary, vaccinia ... "We are excited to enter into a partnership ... time, selected oncolytic vaccinia viruses for use in ...
(Date:2/23/2017)... ... February 23, 2017 , ... David Nolte, ... Recognition Reception at Purdue Research Park of West Lafayette, Indiana. , ... of outstanding contributions to, and success with, commercializing discoveries from Purdue research. “This ...
(Date:2/23/2017)... Therapeutics, Inc. (NASDAQ: CAPR), a biotechnology company developing biological therapies ... Marbán, Ph.D, president and chief executive officer, is scheduled to ... Cowen and Company 37th Annual Health Care Conference Tuesday, March ... 29th Annual ROTH Conference Tuesday, ... Dana Point, CA ...
(Date:2/23/2017)... , ... February 22, 2017 , ... ... photonics , have been named Fellows of the Society this year, the Fellows ... in the multidisciplinary fields of optics, photonics, and imaging as well as their ...
Breaking Biology Technology: